Bar Harbor Wealth Management Horizon Therapeutics Public LTD CO Transaction History

Bar Harbor Wealth Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 09, 2023	BUY	$62.39 - $113.8 $1.86 Million - $3.38 Million	29,735 New	29,735 $3.38 Million
Q4 2022 Jan 19, 2023	SELL	$62.39 - $113.8 $124,592 - $227,258	-1,997 Reduced 6.29%	29,735 $3.38 Million
Q3 2022 Oct 24, 2022	SELL	$58.92 - $84.67 $112,065 - $161,042	-1,902 Reduced 5.65%	31,732 $1.96 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $2.45 Million - $3.59 Million	30,824 Added 1096.94%	33,634 $2.68 Million
Q1 2022 Apr 14, 2022	SELL	$86.42 - $109.81 $50,123 - $63,689	-580 Reduced 17.11%	2,810 $295,000

Q4 2021 Jan 28, 2022	SELL	$98.56 - $119.91 $126,649 - $154,084	-1,285 Reduced 27.49%	3,390 $366,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $21,139 - $25,385	-230 Reduced 4.69%	4,675 $512,000
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $227,242 - $252,749	-2,635 Reduced 34.95%	4,905 $460,000
Q1 2021 May 06, 2021	BUY	$71.83 - $95.48 $5,028 - $6,683	70 Added 0.94%	7,540 $694,000
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $272,690 - $343,467	4,070 Added 119.71%	7,470 $546,000
Q3 2020 Nov 02, 2020	BUY	$55.23 - $79.93 $187,782 - $271,762	3,400 New	3,400 $264,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Bar Harbor Wealth Management with notifications on news.